Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi-center prospective study
- PMID: 16961601
- DOI: 10.1111/j.1538-7836.2006.02091.x
Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi-center prospective study
Abstract
Background: We proposed diagnostic criteria for immune thrombocytopenic purpura (ITP) by modifying the existing guidelines for diagnosis of ITP and by incorporating laboratory tests found useful for predicting its diagnosis, for example erythrocyte count, leukocyte count, anti-GPIIb/IIIa antibody-producing B cells, platelet-associated anti-GPIIb/IIIa antibodies, percentage of reticulated platelets, and plasma thrombopoietin.
Objective and methods: To validate our criteria, we conducted a multi-center prospective study involving 112 patients with thrombocytopenia and a morphologically normal peripheral blood film at the first visit. Each patient underwent a physical examination, routine laboratory tests, and specialized tests for the anti-GPIIb/IIIa antibody response and platelet turnover.
Results: Ninety-one patients (81%) satisfied the proposed criteria at first visit. Clinical diagnosis was made by skilled hematologists > 6 months after the first visit; ITP was diagnosed in 88 patients and non-ITP disorders in 24. The proposed criteria had 98% sensitivity, 79% specificity, a 95% positive predictive value, and a 90% negative predictive value. A relatively low specificity appears to be attributed to a few patients who had both ITP and aplastic anemia or myelodysplastic syndrome.
Conclusions: Our preliminary diagnostic criteria based on ITP-associated laboratory findings were useful for the differential diagnosis of ITP, but additional evaluations and modifications will be necessary to develop criteria that can be used routinely.
Similar articles
-
Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura.Am J Med. 2005 Sep;118(9):1026-33. doi: 10.1016/j.amjmed.2004.12.027. Am J Med. 2005. PMID: 16164890
-
Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).Eur J Haematol. 2012 Feb;88(2):167-74. doi: 10.1111/j.1600-0609.2011.01718.x. Epub 2011 Nov 22. Eur J Haematol. 2012. PMID: 21985182
-
Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.J Clin Invest. 1998 Oct 1;102(7):1393-402. doi: 10.1172/JCI4238. J Clin Invest. 1998. PMID: 9769332 Free PMC article.
-
[Detection of anti-GPIIb-IIIa autoantibodies and its clinical significance in autoimmune thrombocytopenic purpura].Rinsho Byori. 1997 Oct;45(10):934-41. Rinsho Byori. 1997. PMID: 9369070 Review. Japanese.
-
The pathogenesis of chronic immune thrombocytopenic purpura.Semin Hematol. 2007 Oct;44(4 Suppl 5):S3-S11. doi: 10.1053/j.seminhematol.2007.11.002. Semin Hematol. 2007. PMID: 18096470 Review.
Cited by
-
Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision.Int J Hematol. 2020 Mar;111(3):329-351. doi: 10.1007/s12185-019-02790-z. Epub 2020 Jan 2. Int J Hematol. 2020. PMID: 31897887 Free PMC article. No abstract available.
-
High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpura.Int J Hematol. 2020 Mar;111(3):388-395. doi: 10.1007/s12185-019-02808-6. Epub 2020 Jan 2. Int J Hematol. 2020. PMID: 31897888
-
Utility of indium-111 platelet scintigraphy for understanding the mechanism of thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.Exp Hematol Oncol. 2023 May 30;12(1):50. doi: 10.1186/s40164-023-00414-1. Exp Hematol Oncol. 2023. PMID: 37254182 Free PMC article.
-
Comparative analysis of MAIPA assay and PakAuto assay for the diagnosis of primary immune thrombocytopenia.Clin Exp Med. 2025 Aug 7;25(1):282. doi: 10.1007/s10238-025-01831-8. Clin Exp Med. 2025. PMID: 40775095 Free PMC article.
-
Secondary immune thrombocytopenic purpura with renal cell carcinoma.IJU Case Rep. 2019 Aug 2;2(5):250-252. doi: 10.1002/iju5.12088. eCollection 2019 Sep. IJU Case Rep. 2019. PMID: 32743427 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources